Lost To Follow-Up

CHICAGO — Factors such as age, race/ethnicity and insurance type increased risk for loss to follow-up in patients with neovascular age-related macular degeneration, according to a study at the American Academy of Ophthalmology meeting.

NEW YORK — Patients with sickle cell retinopathy had worse visual outcomes if they were lost to follow-up even if they resumed treatment, according to a study.

Signs of social vulnerability such as income, insurance status and race were potentially indicative of participants at risk for loss to follow-up in clinical trials, researchers reported.

WAILEA, Hawaii — In this video from Retina 2021, Caesar K. Luo, MD, discusses an analysis investigating patients with diabetic retinopathy and fluocinolone acetonide implant who were lost to follow-up compared with anti-VEGF monotherapy.

My retina group practice has been contributing data to the American Academy of Ophthalmology’s IRIS Registry since its inception.

Study results showed a high rate of loss to follow-up in patients with neovascular age-related macular degeneration treated with anti-VEGF injections in the U.S., with nearly 1 in 5 patients lost to follow-up.